eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

THE BOOTS COMPANY PLC

1 Thane Road West, Beeston, Nottingham, NG2 3AA
Telephone: +44 (0)1159 595 165
Fax: +44 (0)1159 592 565

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 29/10/2004
SPC Boots Chilblain Cream


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Chilblain Cream


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active ingredient

%w/w

Benzyl alcohol Ph Eur

7.5

Eucalyptus Oil Ph Eur

1.0


Go to top of the page
3. PHARMACEUTICAL FORM

Cream


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

To soothe and heal broken and unbroken chilblains.

For topical administration.


Go to top of the page
4.2 Posology and method of administration

Cream to be applied to affected area and rubbed gently into the skin.


Go to top of the page
4.3 Contraindications

Known Hypersensitivity to any of the ingredients.


Go to top of the page
4.4 Special warnings and precautions for use

If symptoms persist, consult your doctor.

For external use only.

Keep all medicines out of the reach of children.

Chilblain Cream contains Arachis oil (peanut oil) and should not be applied by patients known to be allergic to peanut. As there is a possible relationship between allergy to peanut and allergy to Soya, patients with Soya allergy should also avoid Chilblain Cream.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

The safety of chilblain cream during pregnancy and lactation has not been established, but use during these periods is not considered to constitute a hazard.


Go to top of the page
4.7 Effects on ability to drive and use machines

No adverse effects known.


Go to top of the page
4.8 Undesirable effects

Rarely hypersensitivity reactions.


Go to top of the page
4.9 Overdose

Excessive application of the product may lead to excessive reddening of the skin. Treatment if necessary need only be symptomatic.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Eucalyptus oil has an irritant and rubefacient action on intact skin, providing improved local circulation and a feeling of warmth.

Benzyl alcohol has a weak local anaesthetic activity and reduces the discomfort associated with chilblains.


Go to top of the page
5.2 Pharmacokinetic properties

No data available.


Go to top of the page
5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Purified water

Natrosol 250H

Propylene glycol

Triethanolamine

Methyl parahydroxybenzoate

Stearic acid toilet

Cetyl alcohol

Glyceryl monostearate 40-50

Wool fat

Arachis oil

Silicone fluid F111/20

Butylated hydroxyanisole

Propyl parahydroxybenzoate


Go to top of the page
6.2 Incompatibilities

None


Go to top of the page
6.3 Shelf life

36 months


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C.


Go to top of the page
6.5 Nature and contents of container

A collapsible, internally lacquered, aluminium tube with an HDPE or polypropylene wadless cap.

Pack size: 35g


Go to top of the page
6.6 Special precautions for disposal and other handling

None


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

The Boots Company PLC

Nottingham

NG2 3AA


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 00014/0132


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

First authorisation: 10 November 1971

Last renewal: 25 July 2002


Go to top of the page
10. DATE OF REVISION OF THE TEXT

June 2004



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/11342/SPC/


Active Ingredients/Generics

 
   benzyl alcohol
   eucalyptus oil